FEATURE ARTICLES
The company's head of manufacturing discusses their latest investments in AI and automation, plus offers tips on how any company can start adopting advanced technology.
- Operating And Maintaining Pharmaceutical Gas Distribution Systems
- August 2025 — CDMO Opportunities And Threats Report
- The New FDA Era Of Radical Transparency And Pervasive Oversight
- Building The Biopharma Manufacturing Facility Of The Future Requires A Phased IT/OT Strategy
- 10 Ways To Strengthen U.S. API: Part II
- 10 Ways To Strengthen U.S. API: Part I
- FDA Report Details FY24 Inspections, Shows Big Uptick In Key Countries
PHARMA ONLINE WHITE PAPERS
-
The Complete Flow Cytometry Guide
This guide covers the fundamentals of flow cytometry, aiming to help you better understand how it works, when it is most valuable, and how to conduct an experiment.
-
A Strategic Guide For Biotech And Biopharma Leaders5/15/2025
Securing drug approval is a complex, high-stakes process, and outdated review workflows hinder progress. Explore modern solutions that accelerate timelines without compromising compliance or quality.
-
The Impact Of Artificial Intelligence On CQV7/23/2025
AI is revolutionizing CQV in life sciences by automating documentation, enabling real-time monitoring, and driving predictive quality to boost efficiency and compliance across validation processes.
-
Is Sustainability The Key To Agile Biopharma Manufacturing?3/18/2025
In biologics manufacturing, change is constant. Discover how new innovations and a focus on sustainability have gotten 62% of executives to prioritize eco-friendly practices, which reflects a commitment to long-term viability.
-
Insights And Effective Strategies For A Successful Technology Transfer11/1/2024
Discover key strategies for seamless pharmaceutical technology transfers that accelerate time to market, ensure product quality, and meet regulatory standards across the drug lifecycle.
-
Molecular Properties Of PROTACs And The Relationship To Formulation Design3/4/2025
Here, we conduct a comprehensive analysis of diverse PROTAC (Proteolysis Targeting Chimeras) structures, evaluating their calculated physicochemical properties to identify key trends.
PHARMA ONLINE APP NOTES & CASE STUDIES
- EAD-Based Middle-Down Workflow Analysis
- Automation And Digital Solutions Can Help You Reach Your mRNA Manufacturing And Sustainability Goals
- Global BioPharma Saves Reporting Time On ADA Studies
- Project Management And Strategic Planning Services
- Overcome Common Pre-Filled Syringe Challenges Through Partnership
NEWSLETTER ARCHIVE
- 09.18.25 -- STREAM Edition: Mitigation Strategies For HVAC Recirculation
- 09.17.25 -- Pathway To Approval: Analytical Strategies To Support GLP-1 Receptor Agonist Development
- 09.16.25 -- Reimagining the future of aseptic filling
- 09.16.25 -- EMA Issues Revised Annex 11, New Annex 22, And Associated Documents On Data Governance
- 09.13.25 -- Pharmaceutical Online Best Of August
INDUSTRY NEWS
-
FDA Cracks Down On GLP-1 Imports
GLP-1 bulk drug substances must be detained without physical examination (DWPE) unless they are on a list (Green List) of approved foreign GLP-1 manufacturers.
-
Oregon Court Upholds Drug Price Transparency Law
The law was first enacted in 2018, followed by a lawsuit by Pharmaceutical Research and Manufacturers of America (PhRMA) in 2019, claiming an infringement of free speech for pharmaceutical companies and violation of public property. PhRMA asked the court to bar Oregon from enforcing the law.
-
Spray Drying Market Poised To Nearly Double By 2033
The growth of the spray drying market is attributed to demand for enhanced stability, bioavailability and solubility of poorly soluble drugs.
-
AbbVie Enters Psychedelic Market With Bretisilocin Acquisition
Bretisilocin is a next-generation psychedelic compound (5-HT2A receptor agonist and 5-HT releaser) designed to exert a shorter duration of psychoactive experience, while retaining an extended therapeutic benefit
-
J&J Commits $2 Billion To N.C. Manufacturing Facility
J&J’s latest announcement follows its commitment in March to invest $55 billion to support U.S. manufacturing, R&D, and technology over the next four years.
PHARMACEUTICAL ONLINE CONTENT COLLECTIONS

The modern microbiology laboratory is starting to look very different from the laboratory of even 10 years ago. The work will be similar, yet technology will have advanced. Automation, in particular, is taking center stage. Check out the latest e-book from Pharmaceutical Online.
More Content CollectionsSUPPLIER NEWS
-
GSK Commits $30B To U.S. R&D And Drug Manufacturing Expansion9/17/2025
GSK plc (LSE/NYSE: GSK) today announced plans to invest $30 billion across the United States in research and development and supply chain infrastructure over the next five years.
-
Eli Lilly Announces Plans To Build New $5 Billion Drug Manufacturing Facility In Virginia9/17/2025
Eli Lilly and Company (NYSE: LLY) today announced that it plans to build a $5 billion manufacturing facility just west of Richmond, Virginia, in Goochland County. The new site will be the company's first dedicated, fully integrated active pharmaceutical ingredient (API) and drug product facility for Lilly's emerging bioconjugate platform and monoclonal antibody portfolio.
-
CAI Appoints Jamie Robertson As Vice President Of Mission Critical To Drive Innovation And Operational Excellence Across Global Infrastructure Projects9/14/2025
CAI, a global leader in operational readiness and excellence for high-stakes, regulated environments, is proud to announce the appointment of Jamie Robertson as Vice President of Mission Critical.
-
Körber To Exhibit Aseptic Processing, Packaging, Inspection And MES Software Technologies At Pack Expo 20259/11/2025
Körber, a major international technology group, invites media to visit its booth at Pack Expo 2025 in Las Vegas. This is a unique opportunity to discover how Körber is transforming entrepreneurial thinking into tangible customer success and shaping technological change.
-
Assets Of Sutro Biopharma To Be Auctioned – December 20259/11/2025
Late-model lab R&D and manufacturing equipment surplus to future needs of Sutro biopharma: spray dryer, chromatography systems, Westfalia separators, HPLCs & more.